Quell Therapeutics is a London, UK based, private biopharmaceutical company. Its vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Association, Biotechnology, education
Above €25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Quell Therapeutics? We’re happy to assist you with our Startup Sourcing service.